Staff Awards & Honors
Karin Rodland Named U.S. HUPO Board Member
Congratulations to Dr. Karin Rodland on being selected for the U.S. Human Proteome Organisation (HUPO) Board of Directors. HUPO is an international scientific society representing and promoting proteomics through international cooperation and collaborations. As a member of the U.S. Board of Directors, Rodland will planning strategic and scientific meetings. In addition, she will work to increase HUPO's membership. Her term on the board lasts for three years.
Rodland, lead for National Institutes of Health programs at PNNL, is known for her outstanding proteomics research. Her reputation in applying proteomics to biomarker discovery is evidenced by highly cited review articles and her prominent role in organizing sessions at scientific meetings, such as the International Association for Cancer Research. Her publication record includes 56 peer-reviewed publications, 5 invited review articles, and 5 peer-reviewed publications from 2006 to the present. She holds two patents in DNA technology.